Cargando…
Drug-Induced Liver Injury Due To Losartan
Drug-induced liver injury (DILI) is a challenging diagnosis since a wide variety of medicines can cause adverse reactions. Losartan is an angiotensin II receptor antagonist (ARA-II) approved for the treatment of arterial hypertension. The most common adverse effects are fatigue, anaemia, weakness an...
Autores principales: | Diogo, Joana, Monteiro, Rita, Coelho, Carolina, Ghiletchi, Angela, Leão, Rodrigo, Loureiro, Conceição |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668004/ https://www.ncbi.nlm.nih.gov/pubmed/34912735 http://dx.doi.org/10.12890/2021_002856 |
Ejemplares similares
-
Losartan-induced Pancreatitis
por: Anwar, Shamsuddin M, et al.
Publicado: (2019) -
Q Fever: An Emerging Reality in Portugal
por: Lencastre Monteiro, Rita, et al.
Publicado: (2021) -
Losartan improves intestinal mucositis induced by 5-fluorouracil in mice
por: Oliveira, Maisie Mitchele Barbosa, et al.
Publicado: (2021) -
Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)
por: Hirata, Takumi, et al.
Publicado: (2013) -
Erratum to “Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY)”
por: Hirata, Takumi, et al.
Publicado: (2014)